NCT lookup

Pull any trial record directly from ClinicalTrials.gov.

Implementing PrEP for Women Who Inject Drugs

Active Not RecruitingNA

Sponsor: University of Pennsylvania

Conditions: HIV, Intravenous Substance Abuse, Women's Health, Organization and Administration, Primary Prevention

Interventions: Practice Facilitation

Countries: United States

Women who inject drugs are among the most vulnerable to acquiring HIV, but very few women who inject drugs are prescribed pre-exposure prophylaxis (PrEP) for HIV prevention largely due to barriers within our healthcare system. This research will consider the perspectives of women who inject drugs, healthcare providers, and clinic leadership to improve the way primary care and reproductive health clinics deliver PrEP to women who inject drugs, thereby reducing new HIV infections in this population.

Eligibility overview

Sex: FEMALE

Age: 18 Years to —

Healthy volunteers: Yes

Study type: INTERVENTIONAL

Eligibility criteria

Inclusion Criteria:

To be included in the pilot test of Practice Facilitation, clinics must:

* Complete prior leadership and provider surveys
* Have 50 or more clinic visits with women who inject drugs in the past year
* Have 3 or more clinicians who provide primary and/or reproductive healthcare
* Have leadership willing to participate

Exclusion Criteria:

* None

Locations (1)

Philadelphia, Pennsylvania, United States